| Primary |
| Drug Use For Unknown Indication |
59.3% |
| Product Used For Unknown Indication |
15.2% |
| Renal Transplant |
6.8% |
| Diagnostic Procedure |
3.5% |
| Nuclear Magnetic Resonance Imaging |
2.0% |
| Renal Artery Stenosis |
1.4% |
| Transplant Evaluation |
1.4% |
| Renal Failure Chronic |
1.3% |
| Renal Disorder |
1.0% |
| Scan With Contrast |
1.0% |
| Hypertension |
0.9% |
| Complications Of Transplanted Kidney |
0.9% |
| Back Pain |
0.8% |
| Cerebrovascular Accident |
0.7% |
| Convulsion |
0.7% |
| Angiopathy |
0.7% |
| Peripheral Arterial Occlusive Disease |
0.7% |
| Liver Transplant |
0.6% |
| Nuclear Magnetic Resonance Imaging Brain |
0.6% |
| Osteomyelitis |
0.6% |
|
| Nephrogenic Systemic Fibrosis |
61.1% |
| Nephrogenic Fibrosing Dermopathy |
17.5% |
| Vomiting |
2.9% |
| Wheelchair User |
2.3% |
| Renal Transplant |
1.6% |
| Weight Decreased |
1.5% |
| Oedema Peripheral |
1.4% |
| Sepsis |
1.3% |
| Renal Failure Chronic |
1.2% |
| Urticaria |
1.1% |
| Renal Failure |
1.0% |
| Pain In Extremity |
1.0% |
| Scleroderma |
1.0% |
| Skin Induration |
0.9% |
| Skin Fibrosis |
0.8% |
| Anaphylactoid Reaction |
0.7% |
| Pain |
0.7% |
| Red Blood Cell Target Cells Present |
0.7% |
| Skin Discolouration |
0.7% |
| Skin Lesion |
0.7% |
|
| Secondary |
| Nuclear Magnetic Resonance Imaging |
50.4% |
| Angiogram |
13.5% |
| Nuclear Magnetic Resonance Imaging Brain |
8.3% |
| Imaging Procedure |
4.2% |
| Nuclear Magnetic Resonance Imaging Abdominal |
3.2% |
| Product Used For Unknown Indication |
3.2% |
| Drug Use For Unknown Indication |
3.0% |
| Pain |
2.3% |
| Hypertension |
1.7% |
| Venogram |
1.5% |
| Diagnostic Procedure |
1.2% |
| Fistulogram |
1.1% |
| Anaemia |
1.0% |
| Prophylaxis Against Transplant Rejection |
1.0% |
| Diabetes Mellitus |
0.9% |
| Chemotherapy |
0.9% |
| Computerised Tomogram |
0.8% |
| Venogram Renal |
0.7% |
| Arteriogram |
0.6% |
| Convulsion |
0.6% |
|
| Nephrogenic Systemic Fibrosis |
20.0% |
| Pain |
16.0% |
| Skin Tightness |
14.8% |
| Skin Fibrosis |
9.8% |
| Scar |
7.0% |
| Skin Induration |
6.1% |
| Skin Ulcer |
2.7% |
| Weight Decreased |
2.6% |
| Skin Hypertrophy |
2.6% |
| Swelling |
2.5% |
| Skin Lesion |
2.1% |
| Nephrogenic Fibrosing Dermopathy |
1.8% |
| Skin Plaque |
1.7% |
| Xerosis |
1.6% |
| Anxiety |
1.6% |
| Oedema Peripheral |
1.6% |
| Fibrosis |
1.5% |
| Injury |
1.3% |
| Joint Contracture |
1.3% |
| Joint Range Of Motion Decreased |
1.3% |
|
| Concomitant |
| Nuclear Magnetic Resonance Imaging |
23.8% |
| Ankylosing Spondylitis |
11.9% |
| Fluid Replacement |
7.9% |
| Osteoporosis |
7.9% |
| Aortic Valve Replacement |
4.0% |
| Coronary Artery Bypass |
4.0% |
| Infection Prophylaxis |
4.0% |
| Intervertebral Discitis |
4.0% |
| Osteomyelitis |
4.0% |
| Preoperative Care |
4.0% |
| Productive Cough |
4.0% |
| Prophylaxis Against Gastrointestinal Ulcer |
4.0% |
| Sedative Therapy |
4.0% |
| Drug Use For Unknown Indication |
3.0% |
| Fistulogram |
3.0% |
| Angiogram |
2.0% |
| Venogram |
2.0% |
| Bladder Cancer |
1.0% |
| Hyperparathyroidism Secondary |
1.0% |
| Liver Transplant |
1.0% |
|
| Nephrogenic Systemic Fibrosis |
32.4% |
| Osteomyelitis |
11.8% |
| Nephrogenic Fibrosing Dermopathy |
5.9% |
| Anxiety |
2.9% |
| Fear |
2.9% |
| Injury |
2.9% |
| Rash Macular |
2.9% |
| Renal Failure Acute |
2.9% |
| Renal Impairment |
2.9% |
| Renal Transplant |
2.9% |
| Skin Hypertrophy |
2.9% |
| Transient Ischaemic Attack |
2.9% |
| Unevaluable Event |
2.9% |
| Vaginal Haemorrhage |
2.9% |
| Vascular Access Complication |
2.9% |
| Vasculitis Necrotising |
2.9% |
| Venous Stenosis |
2.9% |
| Vomiting |
2.9% |
| Wheelchair User |
2.9% |
| White Blood Cell Count Decreased |
2.9% |
|
